Audere and South Africa-Based Medical Diagnostech Partner to Bring Africa’s First Home-Grown COVID-19 Antigen Test to Market with Digital Companion App
Retrieved on:
Freitag, März 11, 2022
Research, Technology, Infectious Diseases, Software, Philanthropy, Biotechnology, General Health, Health, Foundation, Science, South African Medical Research Council, ISO, HIV, Disease management, Health Products Regulatory Authority, Pregnancy, Department, Partnership, Research, Public health, Machine learning, Google Play, Accreditation, App Store (iOS/iPadOS), Membrane protein, Investment, Technology Innovation Agency, Bill, SAMRC, Department of Science and Innovation, MD, Artificial intelligence, Capsid, Health equity, SAHPRA, Solution, COVID-19, Innovation, Global health, Bill & Melinda Gates Foundation, Immunity, Severe acute respiratory syndrome coronavirus 2, Infection, Malaria, Medical device, Mobile phone, Pharmaceutical industry, Audere, Medical Diagnostech, AUDERE, MEDICAL DIAGNOSTECH
Access to aggregated test data will provide a comprehensive understanding of disease prevalence, enabling more informed surveillance and disease management.
Key Points:
- Access to aggregated test data will provide a comprehensive understanding of disease prevalence, enabling more informed surveillance and disease management.
- As a South African, I have first-hand experience with the test inequity challenges faced by individuals in my country.
- I feel extreme pride to partner with Medical Diagnostech and support the roll-out of a COVID-19 rapid test made on the continent, for the continent.
- The increased public health reporting capabilities enabled by digitizing rapid diagnostic test result data are crucial to South Africas evolving public health strategy.